BIO_DYS: Bio-feedback Treatment for Dysphagic Post-stroke Patients

Sponsor
IRCCS San Camillo, Venezia, Italy (Other)
Overall Status
Unknown status
CT.gov ID
NCT03247374
Collaborator
(none)
40
1
2
29.1
1.4

Study Details

Study Description

Brief Summary

The primary purpose of the study is to evaluate whether the effect of bio-feedback dysphagia treatment is more effective than a control treatment in post-stroke patients.

This study will be a randomized, single-blind controlled pilot study. The investigators intend to recruit 40 patients who have suffered a stroke and have dysphagia. Twenty patients will undergo training with bio-feedback (experimental group) and the other 20 patients will undergo standard training, using only verbal feedback rather than visual feedback (control group).

The authors hypothesize that in the control group the efficacy of the treatment will be lower in the absence of immediate visual feedback of strength and coordination of the swallowing act.

Condition or Disease Intervention/Treatment Phase
  • Device: "ProComp5 Infiniti" Biofeedback
  • Other: Standard Speech and Language Therapy
N/A

Detailed Description

The procedure is divided into 5 parts:
  • Clinical and instrumental evaluation (fibroendoscopy) of swallowing functions before the treatment;

  • 25 sessions with bio feedback treatment or 25 sessions of control treatment;

  • Clinical and instrumental evaluation (fibroendoscopy) of swallowing functions after the training;

  • Clinical and instrumental evaluation (fibroendoscopy) of swallowing functions after 3 months.

Each participant will attend 5 sessions per week for a total duration of 5 weeks. The duration of each session will take 1 hour, including bio-feedback preparation that will take about 10 minutes for assembly and 5 minutes for removal. At the beginning of the bio-feedback session, a surface electrode will be applied to the mylohyoid muscle. The computer will analyze the electromyographic signal of the patient in real time and will produce visual feedback of the muscular activity on the screen. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favor swallowing strength and efficacy.

During the first session, participant will be instructed to use the tool before starting the training phase. Patients of both groups will participate in similar sessions, with classical maneuvers favoring swallowing efficacy that is effortful swallow, supraglottic swallow, and "Masako" maneuver, the first two with bolus administration, if possible. The experimental group will perform this training for 45 minutes with the support of visualization of muscle activity on the screen (biofeedback), while the control group will attend the same training for 45 minutes, but receiving verbal feedback from the speech and language therapist.

Data analysis

On the measures collected, a descriptive statistical analysis and distribution will be studied. Initial instrumental and clinical data from FOIS scale (The Functional Oral Intake Scale), PAS (Penetration-Aspiration Scale), Pooling Score (Farneti et al.); Cranial nerves test will be analyzed using parametric (t-test) and non-parametric (Wilcoxon test) tests with a p-value considered significant if <0.05, while longitudinal variations will be analyzed using ANOVA for repeated measurements. In addition, the effect size (Cohen's d) of the difference between the instrumental and clinical evaluation scales average before and after training in both groups will be calculated. This will allow to have an estimate of training effectiveness to perform a power study and plan a wider experimental study for validating the method.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
simple randomization into two groupssimple randomization into two groups
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Bio-feedback Treatment Versus Standard Treatment for Dysphagic Post-stroke Patients: a Randomized Controlled Trial
Actual Study Start Date :
Feb 27, 2018
Actual Primary Completion Date :
Nov 1, 2019
Anticipated Study Completion Date :
Aug 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: "ProComp5 Infiniti" Biofeedback

Each participant will attend 5 sessions per week for a total duration of 5 weeks. The duration of each session will take 1 hour, including bio-feedback preparation. At the beginning of the bio-feedback session, a surface electrode will be applied to the mylohyoid muscle. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favour swallowing strength and efficacy: effortful swallow, supraglottic swallow, and "Masako" maneuver, the first two with bolus administration, if possible. The experimental group will perform this training for 45 minutes, plus they will receive a verbal feedback from the speech and language therapist.

Device: "ProComp5 Infiniti" Biofeedback
Each participant will attend 5 sessions per week for a total duration of 5 weeks. At the beginning of the bio-feedback session, a surface electrode will be applied to the mylohyoid muscle. The computer will produce visual feedback of the muscular activity on the screen. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favour swallowing strength and efficacy: they are requested to do classical maneuvers that favour swallowing efficacy that is effortful swallow, supraglottic swallow, and "Masako" maneuver. The experimental group will perform this training for 45 minutes.

Active Comparator: Standard Speech and Language Therapy

Each participant will attend 5 sessions per week for a total duration of 5 weeks. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favour swallowing strength and efficacy: effortful swallow, supraglottic swallow, and "Masako" maneuver, the first two with bolus administration, if possible. The control group will attend this training for 45 minutes, receiving verbal feedback from the speech and language therapist.

Other: Standard Speech and Language Therapy
Each participant will attend 5 sessions per week for a total duration of 5 weeks. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favour swallowing strength and efficacy receiving verbal feedback from the speech and language therapist. They are requested to do classical maneuvers that favour swallowing efficacy that is effortful swallow, supraglottic swallow, and "Masako" maneuver. The control group will perform this training for 45 minutes.

Outcome Measures

Primary Outcome Measures

  1. Change in Functional Oral Intake Scale (FOIS) [Baseline , 4 weeks , finally after 3 months from the end of treatment]

    It is a 7-point scale developed to systematically rate the functional severity of dysphagia

Secondary Outcome Measures

  1. Change in Pooling Score (P-score) [Baseline , 4 weeks , finally after 3 months from the end of treatment]

    The scale is used during clinical endoscopic evaluation to evaluate severity of swallowing disorder, considering excess residue in the pharynx and larynx.The score (minimum 4 - maximum 11) is obtained by the sum of the scores given to the site of the bolus, the amount and ability to control residue/bolus pooling, the latter assessed on the basis of cough, raclage, number of dry voluntary or reflex swallowing acts.

  2. Change in Penetration-Aspiration Scale (PAS) [Baseline , 4 weeks , finally after 3 months from the end of treatment]

    It is a 8-point scale used during endoscopic evaluation that describes and measures the severity of airway invasion during swallowing.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 81 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • first stroke injury

  • single lesion

  • onset from more than six weeks

  • presence of dysphagia (Dysphagia Outcome and Severity Scale ≥ 4)

  • good comprehension ( not below PT 53 in Token Test)

  • good eyesight and hearing, or adequately corrected

Exclusion Criteria:
  • All the elements that hinder a good recording of the electromyographic signal (for instance a cutaneous infection, a wound or a dermatitis in the submandibular area);

  • Severe concomitant illnesses (fever, infections, metabolic problems, serious cardiac insufficiency) that can influence patient's collaboration;

  • Serious dystonia or unintentional movements

  • presence of disorders of consciousness;

  • encephalopathy due to multiple infarcts;

  • inability to sustain the experimental treatment;

  • other neurological diseases (for example Parkinson disease);

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sara Nordio Venice-Lido Italy

Sponsors and Collaborators

  • IRCCS San Camillo, Venezia, Italy

Investigators

  • Principal Investigator: Sara Nordio, IRCCS San Camillo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sara Nordio, Speech and language therapist, IRCCS San Camillo, Venezia, Italy
ClinicalTrials.gov Identifier:
NCT03247374
Other Study ID Numbers:
  • 2017.12 - BioDis
First Posted:
Aug 11, 2017
Last Update Posted:
May 29, 2020
Last Verified:
May 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sara Nordio, Speech and language therapist, IRCCS San Camillo, Venezia, Italy
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 29, 2020